Rethinking the label anti-obesity medication
Pharmacotherapy approved to support people living with obesity has received much attention from the scientific and clinical communities, and general public. Clinical trials have reported substantial effects of these medications, including weight reduction and a reduced risk of cardiac events in people living with obesity.1–4